Effet de différents systèmes de culture à couverture végétale sur le stockage du carbone dans un sol argileux des Hautes Terres de Madagascar

Stocker du carbone dans le sol permet d'améliorer ses propriétés physico-chimiques et de réduire les émissions de dioxyde de carbone vers l'atmosphère. L'effet des systèmes en semis direct avec couverture végétale (SCV) sur le stockage de C dans le sol est étudié sur un dispositif agronomique de longue durée (11 ans) à Antsirabe, Madagascar (16°C, 1 300 mm). Quatre systèmes sont étudiés: un système en labour conventionnel avec exportation des résidus de récolte [CT m/s, rotation maïs (Zea mays L.)-soja (Glycine max. L.)], et trois systèmes en SCV sans travail du sol, et avec restitution des résidus de récolte [NT m/s, rotation maïs-soja; NT m/m-d, rotation maïs-maïs avec une couverture végétale de Desmodium uncinatum; et NT h/s-k, rotation haricot (Phaseolus vulgaris)-soja avec une couverture végétale de Pennissetum clandestinum]. Le sol est très argileux, à faible capacité d'échange cationique mais possédant des propriétés andiques pouvant influencer les potentialités de stockage du C du sol. A 0-5 cm, les teneurs en C sont plus élevées sous SCV (NT m/s, NT m/m-d et NT his) que sous labour (CT m/s), et à 5-10 cm, elles sont plus élevées sous NT m/m-d et NT m/s que sous NT h/s-k et CT m/s. Le stockage annuel de C, à masse de sol équivalente, est de 0,69 et 1,01 mg C.ha-1.an-1, sous NT m/s et NT m/m-d pour l'horizon équivalent à 0-20 cm, alors qu'il n'y a pas d'effet SCV observé pour l'horizon équivalent à 0-40 cm. Ceci peut être dû à la fois à l'absence réelle de stockage comme à une variabilité initiale des teneurs en C dans les horizons de profondeurs, car le labour n'est effectué que jusqu'à 20 cm de profondeur. Les différences de stockage de C entre NT et CT dans la couche 0-20 cm sont essentiellement attribuées aux quantités beaucoup plus importantes de résidus organiques restituées par les systèmes NT par rapport au système labouré CT, mais on peut aussi envisager qu'une partie de cette différence soit le fait d'une perte de C par érosion sous labour. Les teneurs en macroagrégats stables (MA, 200-2 000 [mu]m) sont plus élevées sous NT m/s, NT h/s-k et NT m/m-d que sous CT m/s à 0-5 cm et à 5-10 cm. Cette teneur en MA est corrélée positivement (R = 0,408, p < 0,05, n = 24) avec la teneur en C du sol, ce qui pourrait induire (i) une amélioration de l'agrégation en fonction de l'augmentation de la teneur en C du sol et (ii) une protection du C se trouvant à l'intérieur de ces agrégats contre la minéralisation microbienne. Toutefois, la respirométrie ne montre pas une protection physique de C dans les sites de protection supérieurs à 200 [mu]m pour NT m/s et CT m/s. Dans cette étude, le C stocké dans le sol pourrait alors être protégé contre la minéralisation par d'autres processus comme l'adsorption sur les colloïdes du sol ou la recalcitrance biochimique de la matière organique du sol. (Résumé d'auteur

Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation

Background and Aims: Thrombin levels in the colon of Crohn's disease patients have recently been found to be elevated 100-fold compared with healthy controls. Our aim was to determine whether and how dysregulated thrombin activity could contribute to local tissue malfunctions associated with Crohn's disease. Methods: Thrombin activity was studied in tissues from Crohn's disease patients and healthy controls. Intracolonic administration of thrombin to wild-type or protease-activated receptor-deficient mice was used to assess the effects and mechanisms of local thrombin upregulation. Colitis was induced in rats and mice by the intracolonic administration of trinitrobenzene sulphonic acid. Results: Active forms of thrombin were increased in Crohn's disease patient tissues. Elevated thrombin expression and activity were associated with intestinal epithelial cells. Increased thrombin activity and expression were also a feature of experimental colitis in rats. Colonic exposure to doses of active thrombin comparable to what is found in inflammatory bowel disease tissues caused mucosal damage and tissue dysfunctions in mice, through a mechanism involving both protease-activated receptors -1 and -4. Intracolonic administration of the thrombin inhibitor dabigatran, as well as inhibition of protease-activated receptor-1, prevented trinitrobenzene sulphonic acid-induced colitis in rodent models. Conclusions: Our data demonstrated that increased local thrombin activity, as it occurs in the colon of patients with inflammatory bowel disease, causes mucosal damage and inflammation. Colonic thrombin and protease-activated receptor-1 appear as possible mechanisms involved in mucosal damage and loss of function and therefore represent potential therapeutic targets for treating inflammatory bowel disease

COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

Background and aims: To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN). Methods: Period of observation: March 1st, 2020 March 1st, 2021. Inclusion criteria: patients included in the database since 2015 and still receiving HPN on March 1st, 2020 as well as new patients included in the database during the period of observation. Data related to the previous 12 months and recorded on March 1st 2021: 1) occurrence of COVID-19 infection since the beginning of the pandemic (yes, no, unknown); 2) infection severity (asymptomatic; mild, no-hospitalization; moderate, hospitalization no-ICU; severe, hospitalization in ICU); 3) vaccinated against COVID-19 (yes, no, unknown); 4) patient outcome on March 1st 2021: still on HPN, weaned off HPN, deceased, lost to follow up. Results: Sixty-eight centres from 23 countries included 4680 patients. Data on COVID-19 were available for 55.1% of patients. The cumulative incidence of infection was 9.6% in the total group and ranged from 0% to 21.9% in the cohorts of individual countries. Infection severity was reported as: asymptomatic 26.7%, mild 32.0%, moderate 36.0%, severe 5.3%. Vaccination status was unknown in 62.0% of patients, non-vaccinated 25.2%, vaccinated 12.8%. Patient outcome was reported as: still on HPN 78.6%, weaned off HPN 10.6%, deceased 9.7%, lost to follow up 1.1%. A higher incidence of infection (p = 0.04), greater severity of infection (p < 0.001) and a lower vaccination percentage (p = 0.01) were observed in deceased patients. In COVID-19 infected patients, deaths due to infection accounted for 42.8% of total deaths. Conclusions: In patients on HPN for CIF, the incidence of COVID-19 infection differed greatly among countries. Although the majority of cases were reported to be asymptomatic or have mild symptoms only, COVID-19 was reported to be fatal in a significant proportion of infected patients. Lack of vaccination was associated with a higher risk of death

The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review

BACKGROUND: Short bowel syndrome (SBS) is defined as the malabsorptive state that often follows massive resection of the small intestine. Most cases originate in the newborn period and result from congenital anomalies. It is associated with a high morbidity, is potentially lethal and often requires months, sometimes years, in the hospital and home on total parenteral nutrition (TPN). Long-term survival without parenteral nutrition depends upon establishing enteral nutrition and the process of intestinal adaptation through which the remaining small bowel gradually increases its absorptive capacity. The purpose of this article is to perform a descriptive systematic review of the published articles on the effects of TPN on the intestinal immune system investigating whether long-term TPN induces bacterial translocation, decreases secretory immunoglobulin A (S-IgA), impairs intestinal immunity, and changes mucosal architecture in children with SBS. METHODS: The databases of OVID, such as MEDLINE and CINAHL, Cochran Library, and Evidence-Based Medicine were searched for articles published from 1990 to 2001. Search terms were total parenteral nutrition, children, bacterial translocation, small bowel syndrome, short gut syndrome, intestinal immunity, gut permeability, sepsis, hyperglycemia, immunonutrition, glutamine, enteral tube feeding, and systematic reviews. The goal was to include all clinical studies conducted in children directly addressing the effects of TPN on gut immunity. RESULTS: A total of 13 studies were identified. These 13 studies included a total of 414 infants and children between the ages approximately 4 months to 17 years old, and 16 healthy adults as controls; and they varied in design and were conducted in several disciplines. The results were integrated into common themes. Five themes were identified: 1) sepsis, 2) impaired immune functions: In vitro studies, 3) mortality, 4) villous atrophy, 5) duration of dependency on TPN after bowel resection. CONCLUSION: Based on this exhaustive literature review, there is no direct evidence suggesting that TPN promotes bacterial overgrowth, impairs neutrophil functions, inhibits blood's bactericidal effect, causes villous atrophy, or causes to death in human model. The hypothesis relating negative effects of TPN on gut immunity remains attractive, but unproven. Enteral nutrition is cheaper, but no safer than TPN. Based on the current evidence, TPN seems to be safe and a life saving solution

WHO global research priorities for sexually transmitted infections

Sexually transmitted infections (STIs) are widespread worldwide and negatively affect sexual and reproductive health. Gaps in evidence and in available tools have long hindered STI programmes and policies, particularly in resource-limited settings. In 2022, WHO initiated a research prioritisation process to identify the most important STI research areas to address the global public health need. Using an adapted Child Health and Nutrition Research Initiative methodology including two global stakeholder surveys, the process identified 40 priority STI research needs. The top priorities centred on developing and implementing affordable, feasible, rapid point-of-care STI diagnostic tests and new treatments, especially for gonorrhoea, chlamydia, and syphilis; designing new multipurpose prevention technologies and vaccines for STIs; and collecting improved STI epidemiologic data on both infection and disease outcomes. The priorities also included innovative programmatic approaches, such as new STI communication and partner management strategies. An additional six research areas related to mpox (formerly known as monkeypox) reflect the need for STI-related research during disease outbreaks where sexual transmission can have a key role. These STI research priorities provide a call to action for focus, investment, and innovation to address existing roadblocks in STI prevention, control, and management to advance sexual and reproductive health and wellbeing for all